Home Cart Sign in  
Chemical Structure| 1228591-30-7 Chemical Structure| 1228591-30-7

Structure of TAK-632
CAS No.: 1228591-30-7

Chemical Structure| 1228591-30-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TAK-632 is a selective pan-RAF kinase inhibitor with IC50 values of 2.4/1.4 nM for BRAF V600E/c-RAF with > 60 fold selectivity over VEGFR.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TAK-632

CAS No. :1228591-30-7
Formula : C27H18F4N4O3S
M.W : 554.52
SMILES Code : O=C(C1CC1)NC2=NC3=CC=C(OC4=CC=C(F)C(NC(CC5=CC=CC(C(F)(F)F)=C5)=O)=C4)C(C#N)=C3S2
MDL No. :MFCD26960965
InChI Key :OJFKUJDRGJSAQB-UHFFFAOYSA-N
Pubchem ID :46209401

Safety of TAK-632

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of TAK-632

epigenetics
DNA
MAPK

Isoform Comparison

Biological Activity

Target
  • B-Raf

    B-Raf, IC50:8.3 nM

  • C-Raf/Raf-1

    C-Raf, IC50:1.4 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HFF cells 0.6131 µM 72 h post-infection Evaluate anti-N. caninum activity of TAK-632 in vitro. PMC10921786
THP1-1 cells 10 μM 24 hours To screen a small molecule compound library to identify mechanisms modulating TREM2 surface expression. PMC7948395
HT-29 cells 20 μM 16 hr TAK-632 protected HT-29 cells from TSZ-induced necroptosis PMC6534794

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Neospora caninum infection model Intraperitoneal injection 20, 40, and 60 mg/kg once daily for 10 consecutive days Assess the effects of TAK-632 on parasite burden in vivo. PMC10921786
C57BL/6 J mice TNF-induced systemic inflammatory response syndrome (SIRS) model Oral 100 mg/kg Single dose, 2 hr duration TAK-632 protected mice from TNF-induced SIRS, alleviating hypothermia and death PMC6534794

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.80mL

0.36mL

0.18mL

9.02mL

1.80mL

0.90mL

18.03mL

3.61mL

1.80mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories